Cytokinetics (CYTK) Reports Licensing Collaboration & Royalty Monetization Deals with RTW Investments Focused to CK-3773274, Next-Generation Cardiac Myosin Inhibitor
Go back to Cytokinetics (CYTK) Reports Licensing Collaboration & Royalty Monetization Deals with RTW Investments Focused to CK-3773274, Next-Generation Cardiac Myosin Inhibitor| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 72.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.72 | 52 Week High | $13.18 | |||
| Open | $72.72 | 52 Week Low | $6.00 | |||
| Day High | $72.72 | P/E | N/A | |||
| Day Low | $72.72 | EPS | $-1.24 | |||
| Volume | 4,072 | |||||
